South Dakota Investment Council Sells 14,249 Shares of Encompass Health Corporation $EHC

South Dakota Investment Council reduced its stake in shares of Encompass Health Corporation (NYSE:EHC) by 20.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 54,582 shares of the company’s stock after selling 14,249 shares during the period. South Dakota Investment Council owned 0.05% of Encompass Health worth $6,933,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the stock. Royal Bank of Canada raised its position in shares of Encompass Health by 21.5% during the first quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after acquiring an additional 15,677 shares during the last quarter. Millennium Management LLC increased its position in Encompass Health by 38.4% during the 1st quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock valued at $9,338,000 after purchasing an additional 25,574 shares during the period. Caxton Associates LLP acquired a new position in shares of Encompass Health in the 1st quarter worth approximately $259,000. State of Michigan Retirement System boosted its stake in shares of Encompass Health by 0.4% in the 2nd quarter. State of Michigan Retirement System now owns 24,245 shares of the company’s stock valued at $2,973,000 after purchasing an additional 100 shares during the last quarter. Finally, Machina Capital S.A.S. bought a new position in Encompass Health during the second quarter worth $415,000. Institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have commented on EHC shares. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, January 18th. Zacks Research cut Encompass Health from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 19th. Finally, Barclays boosted their price target on Encompass Health from $150.00 to $153.00 and gave the company an “overweight” rating in a research note on Friday, February 6th. Two analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Encompass Health has an average rating of “Buy” and a consensus price target of $143.29.

Encompass Health Stock Down 0.1%

EHC stock opened at $107.94 on Wednesday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 1.08. Encompass Health Corporation has a fifty-two week low of $92.53 and a fifty-two week high of $127.99. The stock’s 50 day simple moving average is $103.89 and its 200 day simple moving average is $113.88. The company has a market cap of $10.73 billion, a P/E ratio of 19.48, a price-to-earnings-growth ratio of 2.07 and a beta of 0.71.

Encompass Health (NYSE:EHC) last issued its earnings results on Thursday, February 5th. The company reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.29 by $0.17. Encompass Health had a return on equity of 18.20% and a net margin of 9.54%.The company had revenue of $3.09 billion for the quarter, compared to analyst estimates of $1.54 billion. During the same period in the prior year, the firm earned $1.17 earnings per share. Encompass Health’s revenue for the quarter was up 9.9% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 5.810-6.100 EPS. On average, research analysts expect that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st will be given a dividend of $0.19 per share. The ex-dividend date of this dividend is Wednesday, April 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s payout ratio is presently 13.72%.

Insiders Place Their Bets

In other Encompass Health news, CEO Mark J. Tarr sold 150,000 shares of Encompass Health stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $111.64, for a total transaction of $16,746,000.00. Following the completion of the transaction, the chief executive officer owned 377,070 shares in the company, valued at approximately $42,096,094.80. The trade was a 28.46% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.10% of the company’s stock.

About Encompass Health

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.